EVANSTON, Ill.--(BUSINESS WIRE)--Minute Molecular Diagnostics today announced that the U.S. Food and Drug Administration (FDA) granted an Emergency Use Authorization (EUA) for its rapid DASH ...
Medicare Part B covers COVID-19 tests when conducted in laboratories. Part A may cover lab tests if needed in hospital or skilled nursing facility settings. Since 2023, Medicare has no longer covered ...
Building on its leadership in point-of-care diagnostic testing, QuidelOrtho Corporation (Nasdaq: QDEL) ("QuidelOrtho"), a leading global provider of innovative in vitro diagnostic technologies, is ...
Molbio Diagnostics, winner of the businessline Changemaker award 2024, files for IPO with revolutionary Truenat platform for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback